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OBJECTIVE: The importance of type V collagen and its relationships with other types of collagen and with vascular and epithelial 
apoptosis were studied in a model of chemical carcinogenesis in the mouse lung. 
METHODS: Two groups of male Balb/c mice were studied: a) animals that received two intraperitoneal doses of 3 g/kg urethane 
carcinogen (urethane group = 24); and b) animals submitted to a sham procedure, comparable to the test group (control group = 
7). Both groups were sacrificed after 120 days. In situ detection of apoptosis, immunohistochemistry, immunofluorescence and 
histomorphometry were used to evaluate the fraction occupied by the tumor, vascular and epithelial apoptosis, and type V, III and 
I collagen fibers in the lung parenchyma from both groups. 
RESULTS: The lung parenchyma from the urethane group showed low fractions of vascular and epithelial apoptosis as well as 
reduced type V collagen fibers when compared to the control group. A significant direct association was found between type V and 
III collagen fibers and epithelial apoptosis, type V collagen fibers and vascular apoptosis, and type V and type I collagen fibers. 
CONCLUSION: The results show that a direct link between low amounts of type V collagen and decreased cell apoptosis may 
favor cancer cell growth in the mouse lung after chemical carcinogenesis, suggesting that strategies aimed at preventing decreased 
type V collagen synthesis or local responses to reduced apoptosis may have a greater impact in lung cancer control.
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INTRODUCTION
Despite advances in surgery, chemotherapy, and 
radiotherapy over the previous two decades, the death rate for 
lung cancer remains mostly unchanged, and the main cause 
of this is metastasis.1 Thus, there is great interest in methods 
for identifying tumors that are likely to invade, metastasize 
and shorten patient life in order to optimize the therapeutic 
effort for each individual patient. In this regard, our group 
has been studying morphometric and biological markers in 
resected lung cancer and its corresponding lymphatic and 
hematogenous metastatic tissue.2-12 Because lung cancer is 
the phenotypic consequence of interactions between cellular 
and microenvironmental factors (such as blood supply and 
the extracellular matrix) for growth, invasion and metastasis, 
much interest is currently focused on the influence of these 
factors on programmed cell death, or apoptosis.
The extracellular matrix (ECM) contains a significant 
number of “informational” molecules whose interaction 
with scattered cells is of primary importance in the control 
of cellular proliferation and differentiation in cancer 
development.13 One of the most common features of the 
majority of highly invasive tumors, such as lung cancer, 
is massive degradation of the basement membrane.14 
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Additionally, remarkable qualitative and quantitative 
modifications of the interstitial collagen component have 
been described.14-16 Type V collagen is a component of the 
ECM that is located in the pulmonary interstitium and 
capillary basement membranes, and surrounded by vascular 
smooth muscle cells.17 It is a highly conserved protein found 
with the same NH2 terminal end in many animal species, 
making it more immunogenic.18 Normally, this protein 
is not exposed in the ECM, as it is hidden among type I 
and III collagens as a component of heterotypic fibers.19 
Type V collagen, a “minor” component accounting for 
approximately 1% of the total collagen in normal breast 
stroma, was found to be over-deposited in the ECM of breast 
carcinoma, comprising up to 10% of extractable collagens.20 
Subsequently, “in vitro” experiments using breast cancer21 
demonstrated the direct binding of type V collagen epitopes 
to a non-integrin receptor recognized by an anti-elastin/
laminin-binding protein antibody, resulting in a prominent 
retardation of the growth rate and an inhibition of motility 
and invasion.22 More recent results provided evidence that 
type V collagen could trigger apoptosis via caspase 9 in 
breast cancer tissue.20
In light of these previous data suggesting an effect of 
type V collagen on growth inhibition and cell death rate, the 
aim of the present study was to evaluate type V collagen, 
the relationship between type V collagen and other collagen 
types, and epithelial and vascular apoptosis in the lung 
parenchyma of mice modified by chemical carcinogenesis.
MATERIALS AND METHODS
Chemical carcinogenesis model
The experiments to induce chemical carcinogenesis 
in the mouse lung followed the guidelines of the National 
Institutes of Health, after receiving approval from the 
Institutional Review Board for animal experiments.
Twenty-four male Balb/c mice were treated with 3 g/
kg body weight of urethane provided by the pharmacy 
of our teaching hospital. The drug was administered in 
two intraperitoneal injections of 1.5 g/kg, with a 48-
hr interval. A previous study showing this dose to be 
the highest concentration that did not elicit massive 
mortality immediately after injection and that promoted the 
development of identifiable pulmonary nodules within a 
time span of 48 days.23-24 Seven animals were submitted to 
a sham procedure was comparable to that in the test group. 
Animals were randomly assigned to the urethane or control 
groups. After 120 days of lung tumorigenesis induced 
by urethane that resulted in fully developed tumors,23 
24 animals from the urethane group and seven from the 
control group were sacrificed. The animals were sedated, 
anesthetized with 20 mg/kg intraperitoneal pentobarbital 
sodium and exsanguinated by sectioning the caudal aorta. 
The lungs were rapidly removed, dissected, rinsed free 
of blood with saline solution, inflated in situ through the 
trachea at a pressure of 15 mmH2O, measured with respect 
to tidal volume and fixed with 10 ml/kg (0.2 ml) of buffered 
formalin for six hours. Then, the lungs were kept in 70% 
ethanol for 24 hrs at ambient temperature to complete tissue 
fixation. The mediastinal lymph nodes and abdominal organs 
were also examined macroscopically for the presence of 
tumors. Four animals from the urethane group exhibited 
two to three tumors measuring from 3 to 5 mm in the lymph 
nodes. No tumors were observed in the abdominal organs. 
After fixation, tumors in each lung from both groups of 
animals were investigated by examining the pleural and 
the cut surface of sagittal sections of the lung parenchyma. 
All animals from the urethane group presented three to five 
tumors measuring from 5 to 10 mm that were randomly 
scattered in all pulmonary lobes. A routine histological 
procedure was done, and the paraffin-embedded specimens 
were sectioned at 5 m. Each section contained the whole 
cross-sectional area of the lung of each mouse. Lung 
sections were stained with hematoxylin-eosin for tumor 
characterization. Immunostaining for caspase 9 expression 
and end-labeling (TUNEL) were used for in situ apoptosis 
detection. Type I, III and V collagen were detected by 
immunofluorescence. 
Animal tumor characterization
The tumors were submitted to qualitative and quantitative 
histopathological analysis. They were classified according 
to pathological criteria proposed by Kauffman25 and Ward.26 
Two pathologists (ERP and VLC) who were blinded as to 
the group assignment performed the classification. All of 
the tumors from the urethane group were histologically 
characterized as invasive adenocarcinoma with acinar and 
papillary mixed pattern, and the criteria included acini, 
tubules and papillae composed of atypical cuboidal or 
columnar cells invading a loose and uniform desmoplastic 
stroma and replacing the underlying lung architecture 
(Figure 1B). Similar findings were found in metastatic 
adenocarcinoma in the lymph nodes (detail in Figure 1B). 
Caspase 9 immunostaining 
Caspase 9 immunostaining was performed to identify 
apoptosis in the vascular endothelium of lungs from the 
urethane and control groups using an antibody purchased 
from Chemicon (Temecula, Ca, USA, dilution: 1:6000) that 
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is specific for the cleaved form of caspase 9. The Novolink 
Max Polymer (Novocastra Laboratories LTDA), pressure-
cooking antigen retrieval, biotinylated rabbit antimouse 
IgG (Dako Corp; dilution. 1:400), and streptavidin 
were used in combination with biotinylated horseradish 
peroxidase (Dako Corp.; dilution 1:1000), diaminobenzidine 
tetrahydrochloride, and counterstaining with hematoxylin. 
Brownish cytoplasmic staining was considered evidence of 
antigen expression by the cells. 
In situ apoptosis detection
Apoptosis in lung epithelial cells from the urethane 
and control groups was detected by the deoxynucleotidyl 
transferase (TdT) method of end-labeling (TUNEL) 
(Boehringer Mannheim, Mannheim, Germany).27-28 This 
method involves the addition of deoxyuridine triphosphate 
(dUTP) labeled with fluorescein to the ends of the DNA 
fragments by the catalytic action of TdT. Paraffin wax-
embedded sections (3–4 µm) were layered onto glass 
slides. The tissue sections were dewaxed with xylene and 
rehydrated with graded dilutions of ethanol in water. The 
slides were then washed four times with double-distilled 
water for two minutes and immersed in TdT buffer 
(Boehringer Mannheim). The sections were then covered 
with TdT (0.3 U/µl) and fluorescein-labeled dUTP in 
TdT buffer, and the samples were incubated in a humid 
atmosphere at 37°C for 60 minutes. For negative controls, 
TdT was eliminated from the reaction mixture. The sections 
were then incubated with a peroxidase-conjugated antibody 
specific for fluorescein. The staining was observed with a 
substrate system in which nuclei with DNA fragmentation 
were stained brown. The reaction was terminated by washing 
the sections twice in phosphate-buffered saline. Nuclei 
without DNA fragmentation were stained blue as a result of 
counterstaining with hematoxylin.
Immunofluorescence detection of type I, III and V 
collagens
Type I, III, and V collagens in lung ECM from the 
urethane and control groups were detected in sections 
mounted on gamma methacryloxypropyltrimethoxysil
ane-coated (Sigma Chemical Co.) slides. The sections 
were dewaxed in xylene and dehydrated in graded ethanol. 
Antigen retrieval was done by enzymatic treatment of lung 
sections with bovine pepsin (10000 UTD) (Sigma Chemical 
Co.) in acetic acid buffer (pH=2.2) (4 mg/ml) for 30 min at 
37°C. Subsequent incubation with 5% milk in phosphate 
buffer pH=7.0 was performed to block the unspecific 
sites. The slides were then incubated overnight with rabbit 
polyclonal type I (1:100, collagen I from calf skin; Sigma 
Chemical Co., Saint Louis, MO, USA) and V (1:2000, 
collagen V from human placenta; Sigma Chemical Co., 
Saint Louis, MO, USA ), raised in our laboratory according 
to previous works of Miller and colleagues29 and Lane30, 
as well as monoclonal type III collagen (1:100) antibodies 
(Calbiochem, Bioscience Inc. CA). For negative controls, 
sections were incubated with fetal bovine serum instead of 
the primary antibody. The sections were incubated overnight 
at 4°C in a humid atmosphere with the same primary 
antibody diluted with phosphate-buffered saline (PBS) 
plus 1% bovine serum albumin (BSA). After the sections 
were incubated with FITC-conjugated goat anti-rabbit 
immunoglobulins (Sigma Chemical Co., Saint Louis, MO, 
USA; dilution 1:50) diluted in Evans blue 0,006% in PBS 
during 90 min at room temperature. Finally, the section were 
mounted in glicine buffer and analyzed in a fluorescence 
microscopy (Olympus BX 51). 
Figure 1 - Hematoxylin eosin (HE) staining of normal parenchyma of the 
control group (A) and the urethane group, with an adenocarcinogenic area 
and the detail of the adenocarcinogenic metastasis of the lymph node (B). 
Vascular caspase 9 is minimally immunolabeled in the control group (C) 
and shows major expression in the tumor parenchyma (D). Minimal TUNEL 
(+) staining is observed in the normal area (E) of the control group TUNEL 
staining is increased in the tumor parenchyma (F). HE in A,B is at 200x, 
immunohistochemistry for caspase 9 in C,D is at 400x and TUNEL (+) 
apoptosis in E,F is at 400x magnification. 
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Histomorphometry
The area fraction occupied by the tumor in the lung 
parenchyma and the apoptotic fraction of epithelial and 
endothelial cells in lungs from the urethane and control 
groups were evaluated by stereology. At 400x magnification, 
an eyepiece systematic point-sampling grid with 100 
points and 50 lines was used to count the number of points 
overlying positively-stained structures in the nuclei and 
endothelium, respectively.31 To evaluate tumor growth, the 
same procedure was applied to count the number of points 
overlying tumors from the urethane group. Measurements 
were averaged over ten microscopic fields to obtain the 
apoptotic and tumor growth index percentages.
Comparisons were performed in 20% of the slides by 
two observers (ERP and VLC). The coefficient of variation 
for the inter-observer error regarding cell count was < 5%.
Type I, III, and V collagen fibers were quantified in the 
lung ECM from the urethane and control groups by image 
analysis. Briefly, an image analysis system consisting of 
an Olympus camera mounted on an Olympus microscope 
sent the images to an LG monitor by means of a computer-
controlled (Pentium 1330Mhz) digitizing system (Oculus 
TCX, Coreco Inc., St. Laurent, Quebec, Canada). Images 
were processed by ImagePro-Plus 6.0 software (Media 
Cybernetics, Inc., Bethesda, MD, USA). For each lung 
specimen, the ECM compartment in the urethane group 
and ten normal samples of ECM from control groups were 
analyzed at a magnification of 400x. The collagen fiber 
densities in this compartment were expressed as the amount 
of fibers divided by the total area studied. The final results 
are expressed as the number of collagen fibers per total 
area.31
Statistical analysis
The independent t-test was used for analysis of the 
density of collagen fibers and the apoptotic index in the two 
categories. Associations between variables in the TP were 
analyzed using the Spearman test. The level of significance 
was established as p < 0.05. The data were analyzed using 
the SPSS for Windows software (SPSS, Inc., Chicago, IL, 
USA), release 10.0.
RESULTS
Lung parenchyma from the control and urethane groups 
is shown in Figures 1 and 2 as stained by hematoxylin-eosin 
(1A and 1B, detail of adenocarcinoma metastasis to lymph 
node in 1B) and immunostained for vascular apoptosis 
(1C and 1D), epithelial apoptosis (1E and 1F), and type V 
(2A and 2B), type I (2C and 2D) and type III (2E and 2F) 
collagens.
A preserved lung parenchyma sample from the control 
group and an invasive adenocarcinoma from the urethane 
group are shown, respectively, in Figures 1A and 1B. Lung 
parenchyma from the control and urethane groups showed 
scattered vessels and apoptotic epithelial cells (Figure 1C-E 
and Figure 1B-F). A similar green birefringence was found 
for type V and III collagen fibers in the ECM from the lung 
parenchyma of both groups (Figure 2A,B, E, F). Type I 
collagen showed slightly more green birefringence at the 
edge of the tumors, coincident with the more prominent 
desmoplastic reaction at this location (Figure 2C).
The histomorphometric results obtained from the 
measurements of the tumor, vascular and epithelial apoptotic 
areas in the lung parenchyma of the control and urethane 
groups are shown in Table 1.
Invasive adenocarcinoma occupied 7.87% of the 
Figure 2 - The normal parenchyma in the lungs of the control animals 
shows a strong green birefringence of collagen V fibers (A). In contrast, the 
tumor parenchyma (B) shows a diffuse, green birefringence of collagen V 
fibers, which are organized in a reticular texture consisting of thin fibers that 
individually involve tumor cells and complex glands. The collagen III fibers 
show moderate green birefringence in the normal parenchyma (C) when 
compared to the tumor parenchyma (D). A strong green birefringence in the 
normal parenchyma (E) and tumor parenchyma (F) is shown by collagen I 
fibers. Immunofluorescence in A to F is at 400x magnification.
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lung parenchyma. Similar fractions of vascular and 
epithelial apoptosis were detected in lung parenchyma 
from the urethane and control groups. Type V collagen was 
significantly decreased in lung ECM from the urethane 
group compared to the control group (7.01% vs. 16.33%, 
p=0.002). Type I and III collagen fiber fractions were similar 
in the lung ECM from the urethane and control groups 
(Figure 3). 
A significant direct association was found between 
type V and III collagen fibers and epithelial apoptosis 
(R=0.59, p=0.05; R=0.68, p=0.02). Equally significant 
was the association between type V collagen fibers and 
vascular apoptosis (R=7.33, p=0.01). No association was 
found between type I collagen fibers and vascular apoptosis 
(R=0.28, p=0.4). Type V collagen fibers were significantly 
associated with type I collagen fibers (R=0.61, p=0.05) and 
type III collagen fibers (R=0.72, p=0.01).
DISCUSSION
A direct link may exist between decreased type V 
collagen fibers and reduced rate of cell death; such a link 
may favor cancer cell growth in the mouse lung after 
chemical carcinogenesis. Cancer cell growth comprises 
a series of complex, sequential steps. Among these, the 
quantitative modifications of cell apoptosis and changes in 
the interstitial collagen component of the ECM by either 
tumor cells or endothelial cells are thought to be important 
because they facilitate the adhesion and migration of tumor 
cells and the penetration of the tumor by blood vessels.
The structural and molecular features of type V collagen 
have been described extensively over more than a decade,32 
but the biological role of this “minor” component of 
the ECM and the effect of its interactions with different 
cytotypes are still poorly understood. In previous studies, 
our group showed that rabbits immunized with human type 
V collagen, in an attempt to produce the corresponding 
antibodies, developed fibrosis due to collagen deposition 
in vessels and lung parenchyma.33-35 Our group also 
demonstrated prominent fibroblastic cell proliferation 
associated with increased type V collagen deposition in 
humans.36-38 From a review of the literature, a generic and 
unique role played by type V collagen seems unlikely 
because multiple, and sometimes opposite, cellular responses 
are evoked by this collagen substrate, depending upon the 
cell examined. In fact, type V collagen has been proven to 
represent an optimal substrate for the attachment and growth 
of hepatocytes,39 Schwann cells,40 normal smooth muscle 
Figure 3 - Box plots showing the associations among collagen I, III and V 
between the control and urethane groups.
Table 1 - Summary of morphometric resultsa
Variable Group Mean Minimum Maximum
Tumor area (%) Urethane 7.87 1.66 26.56
Vascular apoptosis (%) Urethane 3.45 0.00 8.96
Control 2.19 0.00 7.66
Epithelial apoptosis (%) Urethane 2.05 0.70 3.90
Control 0.48 0.00 2.06
Type V collagen (%) Urethane 7.01* 0.00 12.35
Control 16.33 5.75 36.79
Type III collagen (%) Urethane 24.62 0.00 50.87
Control 33.45 10.73 51.68
Type I collagen (%) Urethane 25.66 35.42 61.78
Control 28.64 0.79 49.09
aThe units “% of points” indicate the number of points overlying the structure of interest divided by the total number of points overlying the tumor. In 
morphometry, this is called a point fraction and is often symbolized as Pp. Pp has been shown to approximate the volume fraction or Vv (30).
*Significantly different from the control (p<0.05).
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cells,41 and some tumor cell types.42 Conversely, an anti-
adhesive and anti-proliferative role of this collagen species 
in neurons,40 various epithelial and endothelial cell lines,43 
and breast cancer cells20 has also been described.
It should therefore not be surprising to learn that 
immunofluorescence staining for type V collagen provides 
important information about the attachment and growth of 
tumor cells, and our results now confirm the importance 
of type V collagen in chemically induced carcinogenesis 
in the mouse lung. Interestingly, our results suggest that 
a decrease in type V collagen fibers is associated with 
decreased apoptosis in epithelial cells and vessels induced 
by nuclear and mitochrondrial mechanisms, respectively, 
thus suggesting that decreased binding of type V collagen 
to epitopes on endothelial cells decreases the synthesis 
of type V collagen by fibroblasts and myofibroblasts 
and results in a reduced desmoplastic stroma reaction in 
tumors. Furthermore, endothelial apoptosis can provoke 
basement membrane injury and exposure of hidden 
type V collagen epitopes, generating new antigens that 
will trigger an immune response with the production of 
fibrogenic cytokines. In fact, it has been shown that type 
V collagen and immune cells may play a role in initiating 
and perpetuating inflammatory and fibrotic responses.44 
Luparello20 demonstrated that an increase in type V collagen 
impairs the survival of breast cancer cells by promoting a 
caspase-dependent apoptotic type of death. Also reported to 
occur was the upregulation of the apoptotic initiator caspases 
8 and 9, the apoptosis-involved caspase 1, and the related 
caspases 5 and 4, as well as a similar increase in the activity 
of some enzyme products.20 Caspases, which are the actual 
cause of death, are responsible for much of the proteolysis 
occurring during apoptosis, and their targets are factors 
involved in the repair, fragmentation, and duplication of 
DNA, in RNA splicing, in the maintenance of cytoskeletal 
integrity, and in cell division.45 In addition to endogenous 
events, such as genomic DNA damage, various extracellular 
ligands (e.g., TNFa, Fas ligand, CD4, CD8, type V collagen) 
have been described to trigger apoptotic cell death or to exert 
an inhibitory effect (e.g., IGF-1 and GM-CSF).46 Thus, the 
density of type V collagen fibers and the apoptotic fraction in 
cells and vessels offer the potential to control tumor growth 
rate, motility and invasion, suggesting that strategies aimed 
at preventing reduced type V collagen synthesis or local 
responses to reduced cellular apoptosis may have a greater 
impact in lung cancer. The finalization of this conclusion 
will require more studies that validate our quantitative 
assessment of type V collagen and apoptosis, as well as the 
gathering of more information at the gene expression level. 
The decreased density of type V collagen fibers in 
the ECM of the urethane group was associated with a 
decrease in other collagen fibers, such as I and III. The 
quantitative difference between the three types of collagen 
was also noticeable; type V collagen was found in a lower 
proportion in the ECM than types I and III. These findings 
are interesting because type I and III collagens are both 
usually upregulated in any type of lung remodeling. In 
the normal lung, small amounts of type V collagen are 
expressed as very thin fibrils in the basement membrane. 
These fibrils contribute to the binding between stromal 
collagen and the basement membrane, which is important 
for cell adhesion and the matrix repair process.17 Previous 
studies demonstrated that type V collagen co-polymerizes 
with type I and III collagens to produce fibrils with smaller 
diameters, thus resulting in a heterotypic assembly as 
a general regulatory mechanism in the control of fibril 
structure and collagen fibrillogenesis.17,32-38 In the current 
study, the noticeably decreased amount of type V collagen 
and consequently decreased co-polymerization with type 
I and III collagens may have facilitated invasion and 
motility and decreased the desmoplastic stroma reaction, 
without affecting the tumor center and the invasion front of 
the tumor. In fact, an inverse correlation between the extent 
of the desmoplastic stroma reaction and the progression of 
carcinomas, similar to the decrease in type V collagen found 
in our study, is described in the literature.14-16 Another question 
that could easily be addressed by the current study is the 
correlation between low type V collagen, low desmoplastic 
stroma, and decreased blood vessel density; low type V 
collagen and probably a non-extensive desmoplastic stroma 
reaction are related to decreased microvessel density and thus 
to hypoxia and decreased nutrient flow. Thus, the decreased 
tumor expression of type V collagen may be more of a 
primary event, and decreased apoptosis may be more of a 
secondary event. Regardless of the mechanism, staining of the 
tumor for type V collagen and apoptosis provides important 
information about chemical carcinogenesis in the mouse lung. 
We conclude that these data represent a good starting 
point for the demonstration of the correlation between type 
V collagen and apoptosis. Further experimental studies 
using electron microscopic observations of interactions 
between type V collagen and cells displaying apoptotic 
features, detailed gene expression analysis, or other assays 
of apoptosis will be necessary. 
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